|
| 1 |
Establishment of Reference Intervals of Cytokeratin 19 Fragment Antigen 21-1 in Korean Adults
Sumi Yoon, Yong Kwan Lim, Hye Ryoun Kim, Mi-Kyung Lee, Oh Joo Kweon
Ann Lab Med.2023;43(1):82-85. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2023.43.1.82
|
|
| 2 |
Word Embedding Reveals Cyfra 21-1 as a Biomarker for Chronic Obstructive Pulmonary Disease
Jeongwon Heo, Da Hye Moon, Yoonki Hong, So Hyeon Bak, Jeeyoung Kim, Joo Hyun Park, Byoung-Doo Oh, Yu-Seop Kim, Woo Jin Kim
|
|
| 3 |
Performances of CYFRA 21-1, Carcinoembryonic Antigen and Their Combination for Lung Cancer Diagnosis
Jin Ju Kim, Hyo Jun Ahn, Yongjung Park
Lab Med Online.2020;10(1):66-74. Published online 2019 December 27
DOI: http://dx.doi.org/10.3343/lmo.2020.10.1.66
|
|
| 4 |
Diagnostic Value of Serum CYFRA 21-1 in Lung Cancer
Hyun Dae Yoon, Ki Deok Kim, Jin Hong Chung, Hyung Woo Lee, Kwan Ho Lee, Hyun Woo Lee, Ihn Ho Cho
|
|
| 5 |
Diagnostic Usefulness of Serum Level of Cyfra 21-1, SCC Antigen and CEA in Lung Cancer
Kyoungah Kim, Me Hwa Lee, Younsuck Koh, Seon Hee Kim, Chae Man Lim, Sang Do Lee, Woo Sung Kim, Dong Soon Kim, Won Dong Kim, Dae Hyuk Moon
|
|
| 6 |
Analysis of Specificity for Tumor Marker CYFRA 21-1 in Patients with Pulmonary Tuberculosis
Hyun Cheol Ha, Jae Sung Lee, Sung Dae Song, Cheol Min Kim, Min Gi Lee, In Joo Kim
|
|
| 7 |
Diagnostic Value of Cyfra 21-1 in Differential Diagnosis of Pleural Effusion
Hak Jun Lee, Kwan Ho Lee, Kyeong Cheol Shin, Chang Jin Shin, Hye Jung Park, Yeung Chul Mun, Kyung Hee Lee, Jin Hong Chung, Myung Soo Hyun, Hyun Woo Lee
|
|
| 8 |
Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer
Sungwook Song, Eun-Hyung Yoo, Hyun-Jung Cho
|
|
| 9 |
Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib
Minkyu Jung, Se Hyun Kim, Soojung Hong, Young Ae Kang, Se Kyu Kim, Joon Chang, Sun Young Rha, Joo Hang Kim, Dae Joon Kim, Byoung Chul Cho
|
|
| 10 |
The CT Findings and the Peak SUV on PET/CT according to the Levels of Cyfra 21-1 and CEA in Patients with Non-Small Cell Lung Carcinoma
Sung Shick Jou, Jai Soung Park, Young Tong Kim, Jung Hwa Hwang, Jeong Mi Park, Jong Kyu Han, Hyung Hwan Kim
|
|
| 11 |
Clinical Effectiveness of Tumor Markers (CEA, NSE, Cyfra 21-1) in Completely Resected Non-small Cell Lung Cancer
Seok Jin Haam, Gil Dong Kim, Sang Ho Cho, Doo Yun Lee
J Lung Cancer.2006;5(2):75-83. Published online 2006 December 18
DOI: http://dx.doi.org/10.6058/jlc.2006.5.2.75
|
|
| 12 |
Relationship between Pre-treatment Serum SCC (squamous cell carcinoma) Antigen, Cyfra 21-1 Levels, and Survival in Squamous Cell Carcinoma of the Uterine Cervix
Ki-Hong Chang, Hee-Sug Ryu, Suk-Joon Chang, Young-Ji Byun, Jung-Pil Lee
|
|
| 13 |
Diagnostic Utility of Pleural Fluid CEA and CYFRA 21-1 for Malignant Pleural Effusions
Jae Ho Chung, Jeong Eun Choi, Moo Suk Park, Sang Yon Hwang, Jin Wook Moon, Young Sam Kim, Joon Chang, Joo Hang Kim, Sung Kyu Kim, Se Kyu Kim
|
|
| 14 |
Diagnostic Value of Serum Cytokeratin 8, 18 and 19 in Lung Cancer
Chang Min Choi, Woo Jin Kim, Jin Young Oh, Young Ae Kang, Chul Gyu Yoo, Choon Taek Lee, Young Whan Kim, Sung Koo Han, Young Soo Shim
|
|
